Fracture Clinical Trials

None

None

None

None

Prospective Randomized Double-Blinded Controlled Multi-Center Clinical Trial Evaluating the Use of Non-Invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

TBD

MRI Assessment of Hip Fracture Risk and Therapy Response in HIV/HCV Coinfection

Project Summary Within a year of hip fracture 20-30% of patients die, and 50% percent lose the ability to walk. A consensus exists that infection with the human immunodeficiency virus (HIV) or the hepatis C virus (HCV) increases the likelihood of fracture risk.

Changes in Bone Quality Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy

HIV exacerbates HCV-related metabolic complications, and coinfected patients have a higher risk of sarcopenia, visceral adiposity, hepatic steatosis, and bone fracture than those with HCV alone, HIV alone, or uninfected persons. Understanding these associations in HIV+/HCV+ patients, how they differ from those of HCV+ and uninfected persons, and their relations …

Use of Digital Tomosynthesis for Detection and Case Management of Scaphoid and Distal Radius Fractures: A Volume RAD Data Collection Study

The test arm will enroll up to 100 volunteers presenting with a wrist injury, consisting of up to 50 volunteers presenting a suspected or confirmed distal radius fracture and up to 50 subjects presenting a suspected or confirmed scaphoid fracture. The control arm will enroll up to 40 healthy volunteers.